Global Oncology Small Molecule Drugs Market Growth (Status and Outlook) 2025-2031

September 2025 | 142 pages | ID: GD77FB33329EN
LP Information

Abstracts

According to this study, the global Oncology Small Molecule Drugs market size will reach US$ million by 2031.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths.

United States market for Oncology Small Molecule Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oncology Small Molecule Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oncology Small Molecule Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oncology Small Molecule Drugs players cover Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oncology Small Molecule Drugs Industry Forecast” looks at past sales and reviews total world Oncology Small Molecule Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Small Molecule Drugs sales for 2025 through 2031. With Oncology Small Molecule Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Small Molecule Drugs industry.

This Insight Report provides a comprehensive analysis of the global Oncology Small Molecule Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Small Molecule Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Small Molecule Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Small Molecule Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Small Molecule Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Small Molecule Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chemotherapy Drugs
• Immunomodulating Drugs
• Targeted Therapy Drugs
• Hormonal Therapy
• Other

Segmentation by Application:

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Lung Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Novartis
• Pfizer
• Celgene
• Bristol-Myers Squibb
• Amgen
• Johnson & Johnson
• AbbVie
• Sanofi
• Takeda
• Eli Lilly
• Bayer
• AstraZeneca
• Astellas
• Merck
• Biogen Idec
• Eisai
• Teva
• Otsuka
• Ipsen
• Gilead Sciences
• Exelixis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncology Small Molecule Drugs Market Size (2020-2031)
  2.1.2 Oncology Small Molecule Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Oncology Small Molecule Drugs by Country/Region (2020, 2024 & 2031)
2.2 Oncology Small Molecule Drugs Segment by Type
  2.2.1 Chemotherapy Drugs
  2.2.2 Immunomodulating Drugs
  2.2.3 Targeted Therapy Drugs
  2.2.4 Hormonal Therapy
  2.2.5 Other
2.3 Oncology Small Molecule Drugs Market Size by Type
  2.3.1 Oncology Small Molecule Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
2.4 Oncology Small Molecule Drugs Segment by Application
  2.4.1 Blood Cancer
  2.4.2 Breast Cancer
  2.4.3 Gastrointestinal Cancer
  2.4.4 Prostate Cancer
  2.4.5 Lung Cancer
  2.4.6 Other
2.5 Oncology Small Molecule Drugs Market Size by Application
  2.5.1 Oncology Small Molecule Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)

3 ONCOLOGY SMALL MOLECULE DRUGS MARKET SIZE BY PLAYER

3.1 Oncology Small Molecule Drugs Market Size Market Share by Player
  3.1.1 Global Oncology Small Molecule Drugs Revenue by Player (2020-2025)
  3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Small Molecule Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ONCOLOGY SMALL MOLECULE DRUGS BY REGION

4.1 Oncology Small Molecule Drugs Market Size by Region (2020-2025)
4.2 Global Oncology Small Molecule Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Small Molecule Drugs Market Size Growth (2020-2025)
4.4 APAC Oncology Small Molecule Drugs Market Size Growth (2020-2025)
4.5 Europe Oncology Small Molecule Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Small Molecule Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Oncology Small Molecule Drugs Market Size by Country (2020-2025)
5.2 Americas Oncology Small Molecule Drugs Market Size by Type (2020-2025)
5.3 Americas Oncology Small Molecule Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oncology Small Molecule Drugs Market Size by Region (2020-2025)
6.2 APAC Oncology Small Molecule Drugs Market Size by Type (2020-2025)
6.3 APAC Oncology Small Molecule Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oncology Small Molecule Drugs Market Size by Country (2020-2025)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type (2020-2025)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncology Small Molecule Drugs by Region (2020-2025)
8.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ONCOLOGY SMALL MOLECULE DRUGS MARKET FORECAST

10.1 Global Oncology Small Molecule Drugs Forecast by Region (2026-2031)
  10.1.1 Global Oncology Small Molecule Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Oncology Small Molecule Drugs Forecast
  10.1.3 APAC Oncology Small Molecule Drugs Forecast
  10.1.4 Europe Oncology Small Molecule Drugs Forecast
  10.1.5 Middle East & Africa Oncology Small Molecule Drugs Forecast
10.2 Americas Oncology Small Molecule Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Oncology Small Molecule Drugs Forecast
  10.2.2 Canada Market Oncology Small Molecule Drugs Forecast
  10.2.3 Mexico Market Oncology Small Molecule Drugs Forecast
  10.2.4 Brazil Market Oncology Small Molecule Drugs Forecast
10.3 APAC Oncology Small Molecule Drugs Forecast by Region (2026-2031)
  10.3.1 China Oncology Small Molecule Drugs Market Forecast
  10.3.2 Japan Market Oncology Small Molecule Drugs Forecast
  10.3.3 Korea Market Oncology Small Molecule Drugs Forecast
  10.3.4 Southeast Asia Market Oncology Small Molecule Drugs Forecast
  10.3.5 India Market Oncology Small Molecule Drugs Forecast
  10.3.6 Australia Market Oncology Small Molecule Drugs Forecast
10.4 Europe Oncology Small Molecule Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Oncology Small Molecule Drugs Forecast
  10.4.2 France Market Oncology Small Molecule Drugs Forecast
  10.4.3 UK Market Oncology Small Molecule Drugs Forecast
  10.4.4 Italy Market Oncology Small Molecule Drugs Forecast
  10.4.5 Russia Market Oncology Small Molecule Drugs Forecast
10.5 Middle East & Africa Oncology Small Molecule Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Oncology Small Molecule Drugs Forecast
  10.5.2 South Africa Market Oncology Small Molecule Drugs Forecast
  10.5.3 Israel Market Oncology Small Molecule Drugs Forecast
  10.5.4 Turkey Market Oncology Small Molecule Drugs Forecast
10.6 Global Oncology Small Molecule Drugs Forecast by Type (2026-2031)
10.7 Global Oncology Small Molecule Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Oncology Small Molecule Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Oncology Small Molecule Drugs Product Offered
  11.1.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Oncology Small Molecule Drugs Product Offered
  11.2.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Oncology Small Molecule Drugs Product Offered
  11.3.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Celgene
  11.4.1 Celgene Company Information
  11.4.2 Celgene Oncology Small Molecule Drugs Product Offered
  11.4.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Celgene Main Business Overview
  11.4.5 Celgene Latest Developments
11.5 Bristol-Myers Squibb
  11.5.1 Bristol-Myers Squibb Company Information
  11.5.2 Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
  11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bristol-Myers Squibb Main Business Overview
  11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Amgen
  11.6.1 Amgen Company Information
  11.6.2 Amgen Oncology Small Molecule Drugs Product Offered
  11.6.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Amgen Main Business Overview
  11.6.5 Amgen Latest Developments
11.7 Johnson & Johnson
  11.7.1 Johnson & Johnson Company Information
  11.7.2 Johnson & Johnson Oncology Small Molecule Drugs Product Offered
  11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Johnson & Johnson Main Business Overview
  11.7.5 Johnson & Johnson Latest Developments
11.8 AbbVie
  11.8.1 AbbVie Company Information
  11.8.2 AbbVie Oncology Small Molecule Drugs Product Offered
  11.8.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AbbVie Main Business Overview
  11.8.5 AbbVie Latest Developments
11.9 Sanofi
  11.9.1 Sanofi Company Information
  11.9.2 Sanofi Oncology Small Molecule Drugs Product Offered
  11.9.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sanofi Main Business Overview
  11.9.5 Sanofi Latest Developments
11.10 Takeda
  11.10.1 Takeda Company Information
  11.10.2 Takeda Oncology Small Molecule Drugs Product Offered
  11.10.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Takeda Main Business Overview
  11.10.5 Takeda Latest Developments
11.11 Eli Lilly
  11.11.1 Eli Lilly Company Information
  11.11.2 Eli Lilly Oncology Small Molecule Drugs Product Offered
  11.11.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Eli Lilly Main Business Overview
  11.11.5 Eli Lilly Latest Developments
11.12 Bayer
  11.12.1 Bayer Company Information
  11.12.2 Bayer Oncology Small Molecule Drugs Product Offered
  11.12.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Bayer Main Business Overview
  11.12.5 Bayer Latest Developments
11.13 AstraZeneca
  11.13.1 AstraZeneca Company Information
  11.13.2 AstraZeneca Oncology Small Molecule Drugs Product Offered
  11.13.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 AstraZeneca Main Business Overview
  11.13.5 AstraZeneca Latest Developments
11.14 Astellas
  11.14.1 Astellas Company Information
  11.14.2 Astellas Oncology Small Molecule Drugs Product Offered
  11.14.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Astellas Main Business Overview
  11.14.5 Astellas Latest Developments
11.15 Merck
  11.15.1 Merck Company Information
  11.15.2 Merck Oncology Small Molecule Drugs Product Offered
  11.15.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Merck Main Business Overview
  11.15.5 Merck Latest Developments
11.16 Biogen Idec
  11.16.1 Biogen Idec Company Information
  11.16.2 Biogen Idec Oncology Small Molecule Drugs Product Offered
  11.16.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Biogen Idec Main Business Overview
  11.16.5 Biogen Idec Latest Developments
11.17 Eisai
  11.17.1 Eisai Company Information
  11.17.2 Eisai Oncology Small Molecule Drugs Product Offered
  11.17.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Eisai Main Business Overview
  11.17.5 Eisai Latest Developments
11.18 Teva
  11.18.1 Teva Company Information
  11.18.2 Teva Oncology Small Molecule Drugs Product Offered
  11.18.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Teva Main Business Overview
  11.18.5 Teva Latest Developments
11.19 Otsuka
  11.19.1 Otsuka Company Information
  11.19.2 Otsuka Oncology Small Molecule Drugs Product Offered
  11.19.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Otsuka Main Business Overview
  11.19.5 Otsuka Latest Developments
11.20 Ipsen
  11.20.1 Ipsen Company Information
  11.20.2 Ipsen Oncology Small Molecule Drugs Product Offered
  11.20.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Ipsen Main Business Overview
  11.20.5 Ipsen Latest Developments
11.21 Gilead Sciences
  11.21.1 Gilead Sciences Company Information
  11.21.2 Gilead Sciences Oncology Small Molecule Drugs Product Offered
  11.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 Gilead Sciences Main Business Overview
  11.21.5 Gilead Sciences Latest Developments
11.22 Exelixis
  11.22.1 Exelixis Company Information
  11.22.2 Exelixis Oncology Small Molecule Drugs Product Offered
  11.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 Exelixis Main Business Overview
  11.22.5 Exelixis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oncology Small Molecule Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Small Molecule Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chemotherapy Drugs
Table 4. Major Players of Immunomodulating Drugs
Table 5. Major Players of Targeted Therapy Drugs
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Other
Table 8. Oncology Small Molecule Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oncology Small Molecule Drugs Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
Table 11. Oncology Small Molecule Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oncology Small Molecule Drugs Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)
Table 14. Global Oncology Small Molecule Drugs Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oncology Small Molecule Drugs Revenue Market Share by Player (2020-2025)
Table 16. Oncology Small Molecule Drugs Key Players Head office and Products Offered
Table 17. Oncology Small Molecule Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oncology Small Molecule Drugs Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oncology Small Molecule Drugs Market Size Market Share by Region (2020-2025)
Table 22. Global Oncology Small Molecule Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oncology Small Molecule Drugs Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oncology Small Molecule Drugs Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oncology Small Molecule Drugs Market Size Market Share by Country (2020-2025)
Table 26. Americas Oncology Small Molecule Drugs Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
Table 28. Americas Oncology Small Molecule Drugs Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)
Table 30. APAC Oncology Small Molecule Drugs Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oncology Small Molecule Drugs Market Size Market Share by Region (2020-2025)
Table 32. APAC Oncology Small Molecule Drugs Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Oncology Small Molecule Drugs Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oncology Small Molecule Drugs Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oncology Small Molecule Drugs Market Size Market Share by Country (2020-2025)
Table 36. Europe Oncology Small Molecule Drugs Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Oncology Small Molecule Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Small Molecule Drugs Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oncology Small Molecule Drugs
Table 42. Key Market Challenges & Risks of Oncology Small Molecule Drugs
Table 43. Key Industry Trends of Oncology Small Molecule Drugs
Table 44. Global Oncology Small Molecule Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Oncology Small Molecule Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Oncology Small Molecule Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Roche Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 49. Roche Oncology Small Molecule Drugs Product Offered
Table 50. Roche Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Novartis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 54. Novartis Oncology Small Molecule Drugs Product Offered
Table 55. Novartis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. Pfizer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 59. Pfizer Oncology Small Molecule Drugs Product Offered
Table 60. Pfizer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Pfizer Main Business
Table 62. Pfizer Latest Developments
Table 63. Celgene Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 64. Celgene Oncology Small Molecule Drugs Product Offered
Table 65. Celgene Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Celgene Main Business
Table 67. Celgene Latest Developments
Table 68. Bristol-Myers Squibb Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 69. Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
Table 70. Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Bristol-Myers Squibb Main Business
Table 72. Bristol-Myers Squibb Latest Developments
Table 73. Amgen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 74. Amgen Oncology Small Molecule Drugs Product Offered
Table 75. Amgen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Amgen Main Business
Table 77. Amgen Latest Developments
Table 78. Johnson & Johnson Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 79. Johnson & Johnson Oncology Small Molecule Drugs Product Offered
Table 80. Johnson & Johnson Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. AbbVie Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 84. AbbVie Oncology Small Molecule Drugs Product Offered
Table 85. AbbVie Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. AbbVie Main Business
Table 87. AbbVie Latest Developments
Table 88. Sanofi Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 89. Sanofi Oncology Small Molecule Drugs Product Offered
Table 90. Sanofi Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Takeda Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 94. Takeda Oncology Small Molecule Drugs Product Offered
Table 95. Takeda Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Eli Lilly Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 99. Eli Lilly Oncology Small Molecule Drugs Product Offered
Table 100. Eli Lilly Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Bayer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 104. Bayer Oncology Small Molecule Drugs Product Offered
Table 105. Bayer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. AstraZeneca Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 109. AstraZeneca Oncology Small Molecule Drugs Product Offered
Table 110. AstraZeneca Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Astellas Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 114. Astellas Oncology Small Molecule Drugs Product Offered
Table 115. Astellas Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Astellas Main Business
Table 117. Astellas Latest Developments
Table 118. Merck Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 119. Merck Oncology Small Molecule Drugs Product Offered
Table 120. Merck Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Merck Main Business
Table 122. Merck Latest Developments
Table 123. Biogen Idec Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 124. Biogen Idec Oncology Small Molecule Drugs Product Offered
Table 125. Biogen Idec Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Biogen Idec Main Business
Table 127. Biogen Idec Latest Developments
Table 128. Eisai Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 129. Eisai Oncology Small Molecule Drugs Product Offered
Table 130. Eisai Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Eisai Main Business
Table 132. Eisai Latest Developments
Table 133. Teva Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 134. Teva Oncology Small Molecule Drugs Product Offered
Table 135. Teva Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Teva Main Business
Table 137. Teva Latest Developments
Table 138. Otsuka Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 139. Otsuka Oncology Small Molecule Drugs Product Offered
Table 140. Otsuka Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Otsuka Main Business
Table 142. Otsuka Latest Developments
Table 143. Ipsen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 144. Ipsen Oncology Small Molecule Drugs Product Offered
Table 145. Ipsen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Ipsen Main Business
Table 147. Ipsen Latest Developments
Table 148. Gilead Sciences Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 149. Gilead Sciences Oncology Small Molecule Drugs Product Offered
Table 150. Gilead Sciences Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Gilead Sciences Main Business
Table 152. Gilead Sciences Latest Developments
Table 153. Exelixis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 154. Exelixis Oncology Small Molecule Drugs Product Offered
Table 155. Exelixis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. Exelixis Main Business
Table 157. Exelixis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Small Molecule Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Small Molecule Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Small Molecule Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Small Molecule Drugs Sales Market Share by Country/Region (2024)
Figure 8. Oncology Small Molecule Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Small Molecule Drugs Market Size Market Share by Type in 2024
Figure 10. Oncology Small Molecule Drugs in Blood Cancer
Figure 11. Global Oncology Small Molecule Drugs Market: Blood Cancer (2020-2025) & ($ millions)
Figure 12. Oncology Small Molecule Drugs in Breast Cancer
Figure 13. Global Oncology Small Molecule Drugs Market: Breast Cancer (2020-2025) & ($ millions)
Figure 14. Oncology Small Molecule Drugs in Gastrointestinal Cancer
Figure 15. Global Oncology Small Molecule Drugs Market: Gastrointestinal Cancer (2020-2025) & ($ millions)
Figure 16. Oncology Small Molecule Drugs in Prostate Cancer
Figure 17. Global Oncology Small Molecule Drugs Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. Oncology Small Molecule Drugs in Lung Cancer
Figure 19. Global Oncology Small Molecule Drugs Market: Lung Cancer (2020-2025) & ($ millions)
Figure 20. Oncology Small Molecule Drugs in Other
Figure 21. Global Oncology Small Molecule Drugs Market: Other (2020-2025) & ($ millions)
Figure 22. Global Oncology Small Molecule Drugs Market Size Market Share by Application in 2024
Figure 23. Global Oncology Small Molecule Drugs Revenue Market Share by Player in 2024
Figure 24. Global Oncology Small Molecule Drugs Market Size Market Share by Region (2020-2025)
Figure 25. Americas Oncology Small Molecule Drugs Market Size 2020-2025 ($ millions)
Figure 26. APAC Oncology Small Molecule Drugs Market Size 2020-2025 ($ millions)
Figure 27. Europe Oncology Small Molecule Drugs Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Oncology Small Molecule Drugs Market Size 2020-2025 ($ millions)
Figure 29. Americas Oncology Small Molecule Drugs Value Market Share by Country in 2024
Figure 30. United States Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Oncology Small Molecule Drugs Market Size Market Share by Region in 2024
Figure 35. APAC Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
Figure 36. APAC Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)
Figure 37. China Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. India Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Oncology Small Molecule Drugs Market Size Market Share by Country in 2024
Figure 44. Europe Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
Figure 45. Europe Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Germany Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. France Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Oncology Small Molecule Drugs Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 60. APAC Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 61. Europe Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 63. United States Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 64. Canada Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 65. Mexico Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 66. Brazil Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 67. China Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 68. Japan Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 69. Korea Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 71. India Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 72. Australia Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 73. Germany Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 74. France Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 75. UK Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 76. Italy Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 77. Russia Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 78. Egypt Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 79. South Africa Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 80. Israel Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 81. Turkey Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)
Figure 82. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Oncology Small Molecule Drugs Market Size 2026-2031 ($ millions)